Co-founder and chief executive of American biotechnology company Regeneron Pharmaceuticals.
In July 2020, Regeneron was awarded a $450 million dollar contract under Operation Warp Speed for its REGN-COV2, an artificial "antibody cocktail" which was undergoing clinical trials at the time. When President Trump was infected with COVID in October 2020, he was given REGN-COV2.
March 4, 2022 Medicine/Pharmaceutical